ASIT BIOTECH S.A.

Share · BE0974289218 · A2AJLU (XBRU)

No Price

n/a

Company Profile for ASIT BIOTECH S.A. Share

DMS Imaging SA, a biopharmaceutical company, focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies in Belgium and internationally. Its lead product is gp-ASIT+, which is in the Phase III trial for the treatment of grass pollen rhinitis. The company is also developing hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy. ASIT Biotech S.A. was incorporated in 1997 and is based in Liege, Belgium.

Get up to date insights from finAgent about ASIT BIOTECH S.A.

Company Data

Name ASIT BIOTECH S.A.

Company DMS Imaging S.A.

Website https://www.dms-imaging.com

Primary Exchange

EURONEXT - EURONEXT BRUSSELS

WKN A2AJLU

ISIN BE0974289218

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Thierry Legon

Country Belgium

Currency EUR

Employees 0,0 T

Address 7 Rue des Chasseurs Ardennais, Liege (Angleur), 4031 Liege

IPO Date 2016-05-11

Ticker Symbols

Name	Symbol
EURONEXT - EURONEXT BRUSSELS	ASIT.BR
Frankfurt	AS0.F
London	0RGO.L

More Shares

Investors who hold ASIT BIOTECH S.A. also have the following shares in their portfolio:

Harrow, Inc. - 11.875% Senior Notes due 2027 Share

Vanguard Total Bond Market II Idx I Fund

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog